A validation experience of patient education material on anticoagulation in an outpatient clinic

Experiencia de validación de material educativo pacientes anticoagulados en un servicio de consulta externa.

Anticoagulation therapy is indicated in thrombotic processes and requires a comprehensive management for decreasing adverse events. Follow-up measures include monitoring, surveillance and continuous education by means of creating pedagogic alternatives which facilitate the reception and appropriation of information. Objective: to validate educational materials for patients attending the hematology service undergoing anticoagulation therapy. Methodology: a three-phase process including bibliographic search, construction and design of education materials and validation. The last phase included two steps, technical validation and community surveillance. Results: 19 documents were identified but did not report on validation processes. Based on the analysis of the available documents it was considered that an educational booklet was the most appropriate material for this population. Discussion: patient education materials are a frequently used tool by health systems, as supplement to care provided outside the doctor´s office, but rigorous validation processes of this type of materials on hematology are scarce. 

1. Dupras D, Bluhm J, Felty C, et al. Institute for Clinical Systems Improvement. Health care guideline: venous thromboembolism diagnosis and treatment. Updated: January, 2013. www.icsi.org/_asset/5ldx9k/VTE0113.pdf
2. Flores Gutiérrez, M. Factores de riesgo en enfermedad tromboembólica venosa. Ortho-tips Vol. 4 No. 2 2008 www.medigraphic.com/pdfs/orthotips/ot-2008/ot082c.pdf
3. Goldman L, Schafer A. Trastornos trombóticos: estados de hipercoagulabilidad. In: Elseiver, editor. Cecil y Goldman Tratado de medicina interna 179 2013. p. 1152-8.
4. Goldhaber S. Risk Factors for Venous Thromboembolism. Journal of the American College of Cardiology; 2010. p. 1-7.
5. Guyatt G, Elie A, Crowther M, Gutterman D, Schü H. Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest; 2012. p. 7-47.
6. Leewen V, Rosendaal FR, Cannegieter C. Prediction of hemorrhagic and thrombotic events in patients with mechanical heart valve prostheses treated with oral anticoagulants. Journal of Thrombosis and Haemostasis. 2007;6:451–6.
7. Tourneau t, Lim V, Tourneau T, Inamo J, Miller F, Mahoney D, et al. Achieved Anticoagulation vs Prosthesis Selection for Mitral Mechanical Valve Replacement: A Population-Based Outcome Study Chest. 2009;136(6):1503-13.
8. Schulman S, Crowther M. How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch. Blood. 2012;119(13):3016-23
9. Shore S, Ho pH, Lambert A, Glorioso TH, Carey EP, Cunningham F, et al. Site-level variation in and practices associated with dabigatran adherence. JAMA. 2015;313(14):1443-50.
10. Pantaleón B, Salazar So, Triana M, Aldama A, Garrido M, Alonso M. Introducción del control terapéutico en el seguimiento de pacientes tratados con anticoagulantes orales. Rev Cubana Invest Bioméd [Internet]. 2009 Mar [citado 2016 Oct 25] ; 28( 1 ): . Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002009000100004&lng=es.
11. Taboada L, Silva L, Montenegro A. Beneficios de la clínica de anticoagulación. Acta Med Colomb [Internet]. 2013 Oct [cited 2016 Oct 25] ; 38( 4 ): 239-243. Available from: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-24482013000400010&lng=en
12. Phillips KW, Ansell J. Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management. Expert Rev Cardiovasc Ther 2008; 6(1): 57-70.
13. Wilson SJ, Wells PS, Kovacs MJ, Lewis GM, Martin J, Burton E, et al. Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. CMAJ 2003; 169(4): 293-8.
14. Organización Mundial de la Salud. Promoción de la Salud, Glosario. Ginebra: OMS; 1998. Consultado 21 octubre 2016.13. Disponible en https://www.msssi.gob.es/profesionales/saludPublica/prevPromocion/docs/glosario.pdf
15. Buitrago L, Casas C, Solano M. Trombosis inusuales y trombofilia Un problema difícil de abordar. Experiencia de cuatro años, Acta Médica Colombiana. 2013;38(3):132-7.
16. Solano M, Mendieta F. Adherencia al tratamiento anticoagulante Hospital de San Jose Bogota D.C Colombia. Repertorio de Medicina y Cirugía. 2014;23(3):189-98.
17. Ziemendorff S, Krause A. Guía de validación de materiales educativos (Con enfoque en materiales de Educación Sanitaria) 2003:[1-74 pp.]. Available from: http://www.bvsde.paho.org/tutorialin/pdf/eduperu.pdf
18. Salud Madrid. Guía de recomendaciones al paciente anticoagulado 2006.
19. Clínica de anticoagulacion Valle de Lili. Anticoagulacion con heparinas de bajo peso molecular. p. 1-7.
20. Clínica de Anticoagulacion Valle de Lili. Terapia de anticoagulación con warfarina. SF.
21. Younger, E.,Et al. Guia para el diseño y elaboración de materiales informativos sobre vacunación y salud infantil. Washington: PAHO 2001.
22. Barrio Cantalejo, I.,Et al. Opinión de los pacientes sobre la legibilidad de los folletos de educación para la salud. Index de Enfermería. 2008; 17(4)7.
23. García J. Lectura crítica. Modelo de comunicación para el aprendizaje independiente y de la clínica. Revista médica del Instituto Mexicano del Seguro social 2000;38:61-8.
24. Gervas J, Hernández A, Marti P, Garcia-Sagredo P, Elvira P, Estevez A, et al. La comunicación médico paciente y la educación para la salud. Atención primaria. 1991;8(3):40-5.